El objeto del contrato viene determinado por el suministro del suministro de los principios activos denominados"Mirikizumab 100 mg/1ml pluma precargada subcutanea (OMVOH)" "Mirikizumab 300 mg vial 15 mlintravenosa (OMVOH)" Y "Selpercatinib 40 mg capsula oral
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Apr 15,Expired
- Award
- Price only
- Agreement
- Buying goodsover 1 year
Brief
La Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín ha modificado un contrato con LILLY, S.A. para el suministro de los principios activos "Mirikizumab 100 mg/1ml pluma precargada subcutánea (OMVOH)", "Mirikizumab 300 mg vial 15 ml intravenosa (OMVOH)" y "Selpercatinib 40 mg cápsula oral" por un período de 12 meses.
Farmasøytisk engroshandel
Result
- LILLY, S.A.Winner
- 0Number of bids
- Not statedContract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
PRECIO.
Source
From the notice on TED
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
From the notice
Dicho objeto corresponde al código 33690000-3 Medicamentos diversos, de la nomenclatura Vocabulario Común de Contratos (CPV) de la Comisión Europea.
Contact
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrínucahugcdn.scs@gobiernodecanarias.org- ResultType
- Gran CanariaLocation
- 33690000Main codeVarious medicinal products